Insider Selling: Axon Enterprise, Inc. (NASDAQ:AXON) Director Sells 307 Shares of Stock

Axon Enterprise, Inc. (NASDAQ:AXON) Director Jeri Williams sold 307 shares of the firm’s stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the sale, the director now directly owns 1,627 shares in the company, valued at approximately $899,275.44. The trade was a 15.87 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Axon Enterprise Price Performance

Shares of NASDAQ:AXON opened at $568.11 on Thursday. The company has a market capitalization of $43.53 billion, a P/E ratio of 146.80, a P/E/G ratio of 5.17 and a beta of 1.12. Axon Enterprise, Inc. has a 1-year low of $273.52 and a 1-year high of $715.99. The firm’s 50 day simple moving average is $592.48 and its two-hundred day simple moving average is $539.47. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of AXON. Capital World Investors raised its holdings in Axon Enterprise by 86.4% during the fourth quarter. Capital World Investors now owns 1,815,765 shares of the biotechnology company’s stock valued at $1,079,145,000 after acquiring an additional 841,772 shares during the period. Alliancebernstein L.P. grew its position in shares of Axon Enterprise by 273.8% during the fourth quarter. Alliancebernstein L.P. now owns 1,109,045 shares of the biotechnology company’s stock worth $659,128,000 after purchasing an additional 812,337 shares in the last quarter. Norges Bank bought a new stake in Axon Enterprise during the 4th quarter valued at approximately $482,081,000. GQG Partners LLC purchased a new position in Axon Enterprise in the 4th quarter worth approximately $478,349,000. Finally, Groupama Asset Managment bought a new position in Axon Enterprise in the 3rd quarter worth approximately $200,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Wall Street Analyst Weigh In

AXON has been the topic of several research reports. Northcoast Research cut shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a report on Wednesday, February 19th. Robert W. Baird raised their price target on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Needham & Company LLC reaffirmed a “buy” rating and issued a $600.00 price objective on shares of Axon Enterprise in a report on Wednesday, February 26th. The Goldman Sachs Group increased their target price on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a report on Monday, January 27th. Finally, TD Cowen started coverage on Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 price target for the company. One analyst has rated the stock with a sell rating, two have given a hold rating and eleven have issued a buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $604.67.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.